Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients

BACKGROUND: Immunotherapy has become a standard‐of‐care for patients with non‐small‐cell lung cancer (NSCLC). Although several biomarkers, such as programmed cell death‐1, have been shown to be useful in selecting patients likely to benefit from immune checkpoint inhibitors (ICIs), more useful and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Oku, Yuka, Toyokawa, Gouji, Wakasu, Sho, Kinoshita, Fumihiko, Takamori, Shinkichi, Watanabe, Kenji, Haratake, Naoki, Nagano, Taichi, Kosai, Keisuke, Takada, Kazuki, Fujimoto, Airi, Higashijima, Kodo, Shiraishi, Yoshimasa, Tanaka, Kentaro, Takeoka, Hiroaki, Okamoto, Masaki, Yamashita, Takanori, Shimokawa, Mototsugu, Shoji, Fumihiro, Yamazaki, Koji, Okamoto, Tatsuro, Seto, Takashi, Ueda, Hitoshi, Takeo, Sadanori, Nakashima, Naoki, Okamoto, Isamu, Takenaka, Tomoyoshi, Yoshizumi, Tomoharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358235/
https://www.ncbi.nlm.nih.gov/pubmed/37211905
http://dx.doi.org/10.1002/cam4.6110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358235/
https://www.ncbi.nlm.nih.gov/pubmed/37211905
http://dx.doi.org/10.1002/cam4.6110

Ejemplares similares